M&A Deal Summary |
|
---|---|
Date | 2012-01-01 |
Target | Spepharm Ag |
Sector | Life Science |
Buyer(s) |
Norgine
SpePharm Holding B.V. |
Deal Type | Joint Venture |
SEARCH BY
Try For Free 7-Day Free Trial
Norgine is an independent specialty pharmaceutical company. Norgine’s focus is the development and marketing of pharmaceutical products that address significant unmet clinical needs in therapeutic areas such as gastroenterology, hepatology, and critical and supportive care. Norgine was formed in 1906 and is based in Amsterdam, Netherlands.
DEAL STATS | # |
---|---|
Overall | 2 of 5 |
Sector (Life Science) | 2 of 4 |
Type (Joint Venture) | 1 of 1 |
Country (Switzerland) | 1 of 1 |
Year (2012) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2009-10-26 |
Alizyme - cetilistat
United Kingdom Alizyme - cetilistat is a drug designed to treat obesity. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2015-04-01 |
Endocuff
Leeds, United Kingdom ARC Medical Design Ltd. is a provider of medical products. ARC Medical Design was founded in 2008 and is based in Leeds, United Kingdom. |
Buy | - |
SpePharm Holding B.V. is a specialty pharmaceutical company, engages in acquiring, registering, and marketing specialty medicines, essentially for the hospital market.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Life Science) | 1 of 1 |
Type (Joint Venture) | 1 of 1 |
Country (Switzerland) | 1 of 1 |
Year (2012) | 1 of 1 |